USPTO Director Vacates and Remands PTAB’s Institution Decision Over Insufficient Explanation of Findings

April 25, 2024

Reading Time : 2 min

The USPTO Director vacated a Patent Trial and Appeal Board decision denying institution of inter partes review for not addressing alleged differences between references in the petition and those considered during prosecution. The Director determined that the board did not sufficiently explain its findings and remanded for further proceedings.

Petitioner filed IPR petitions challenging three related patents and the patent owner responded with preliminary responses arguing that the petitions should be denied on the basis that “the same or substantially the same prior art or arguments previously were presented to the Office.” 325 U.S.C. § 325(d); see Advanced Bionics, LLC v. MED-EL Elektromedizinische Geräte GmbH, IPR2019-01469, Paper 6 at 8 (PTAB Feb. 13, 2020) (precedential) (providing a two-part framework for discretionary denial on this basis). Petitioner’s references in the IPRs were not identical to those previously presented to the Office and petitioner alleged material differences between the two sets of references.

The board sided with the patent owner and denied institution of all three IPRs without disagreeing with, or finding immaterial, petitioner’s alleged differences between the IPR and prosecution references. For example, in one IPR, the board simply stated that it was “unpersuaded” regarding petitioner’s contentions, but did not provide explanation or analysis to support its conclusion. Petitioner requested Director Review, arguing that the board did not address the substance of the arguments and, instead, improperly “focused on the similarity of the claim limitations covered by the references, rather than on assessing the…content of the references.”

The Director determined that the board failed to adequately explain its analysis of whether substantially the same prior art or substantially the same arguments were previously presented (i.e., the first prong of the Advanced Bionics framework). In particular, the board did not disagree with petitioner’s explanation of the alleged differences in the references, it did not find those differences to be immaterial, and it did not provide a sufficient comparison of what was previously considered to what was submitted by the petitioner in the IPRs. The Director explained that the board must address the alleged differences to resolve whether substantially the same references were previously considered and simply comparing individual elements of the references is insufficient without more analysis. Similarly, relying on vague or high-level similarities cannot substitute for detailed reasoning, such as identifying substantive and material overlap between the references or determining that the petitioner’s and examiner’s arguments rely on the same rationale.

Practice Tip: If references or arguments in a petition are similar to ones previously before the Office, petitioners should clearly identify substantive differences to distinguish the petition over earlier proceedings. Patent owners seeking an institution denial based on the similarity of references or arguments should provide examples demonstrating the overlap, or immateriality of any alleged differences, between references. Conversely, should the board not provide sufficient explanation of its findings under the first prong of the Advanced Bionics framework, petitioners would be well advised to seek to vacate a decision denying institution.

Nokia of America Corp. v. Alexander Soto, IPR2023-00680, -00681, -00682, Paper No. 18 (Vidal Mar. 28, 2023)

Share This Insight

Previous Entries

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

IP Newsflash

January 17, 2025

The District of Arizona recently held that a plaintiff’s failure to mark patented products during the time period that marking was required barred it from recovering all pre-notice damages, including for a period of time when there was no obligation to mark.

...

Read More

IP Newsflash

January 16, 2025

The Unified Patent Court (UPC) aims to provide expeditious decisions for its litigants. That means that there is a higher bar for obtaining extensions of time. As exemplified in BMW v. ITCiCo, the UPC’s reluctance to grant extensions can have serious consequences, including revocation of the patent.

...

Read More

IP Newsflash

January 15, 2025

The Patent Trial and Appeal Board granted institution of inter partes review of a patent directed to delivery of targeted television advertisements. The board rejected patent owner’s argument that a lack of particularity as to the asserted grounds justified denial under 35 U.S.C. § 312(a), holding that “simply including a significant amount of testimony and a number of supporting references is not, by itself, a reason to find that the particularity requirement is not met.”

...

Read More

IP Newsflash

December 2, 2024

The Patent Trial and Appeal Board determined that a reference could be used as prior art because patent owner failed to provide sufficient evidence that the prior art’s disclosure was invented by all four named inventors, and thus the same “inventive entity,” as the challenged claims.

...

Read More

IP Newsflash

December 2, 2024

The Patent Trial and Appeal Board rejected a patent owner’s assertion that petitioner should have named a third party, which was a defendant in a related district court patent infringement litigation and a party to a joint defense agreement (JDA) with petitioner, as a real party-in-interest (RPI). Had the board ruled otherwise and found the third party to be an RPI, the petition would have been time-barred under 35 U.S.C. § 315(b).

...

Read More

IP Newsflash

November 27, 2024

A district court recently refused to exclude testimony regarding consumer surveys conducted by a design patent expert, holding instead that the consumer surveys may be probative of how an ordinary observer would view the designs at issue, and thus could assist the factfinder in determining design patent infringement under the ordinary observer test.

...

Read More

IP Newsflash

November 5, 2024

The Federal Circuit vacated a district court’s fee award because the district court considered certain information that was not relevant to the question of whether plaintiff’s case was exceptional. Specifically, the Federal Circuit held that only those “red flags” that related to the successful Section 101 defense, which served as the basis for the district court’s grant of summary judgment, could be used to show the case was fatally flawed.   

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.